Please reload

A US drugmaker offers to cure rare blindness for $850,000

January 9, 2018

Spark Therapeutics' Luxturna will cost $850,000 for a one-time treatment.

  • The gene therapy treats a rare, inherited retinal disease that can lead to blindness.

  • Spark also unveiled a set of payment and access programs, including tying payments to how well the therapy works and exploring payment by installment.

  • These programs could serve as a model as more one-time treatments come to market.

Read entire article...











Share on Facebook
Please reload

Follow Us
Please reload

  • Facebook Basic Square

Philadelphia eyeglasses. The city's largest selection of affordable funky eyeware. Eyes examined. Contact lenses. Lab on premises.